Hypertension and renal disease risk. Eyes on the end result.
Long
Janet B
JB
Rhode Island Cardiology Center, Providence, USA.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001794:Blood Pressure / Q000502:physiology*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D005919:Glomerular Filtration Rate; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000503:physiopathology; D051436:Renal Insufficiency, Chronic / Q000209:etiology* / Q000503:physiopathology; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D049993:Sodium Chloride Symporter Inhibitors